Fineline Cube

Follow:
14409 Articles
NHSA to Announce NRDL Adjustment Results at November 28th Press Conference
Policy / Regulatory

NHSA to Announce NRDL Adjustment Results at November 28th Press Conference

NMPA and Local Governments Streamline Drug Approval Processes in China
Policy / Regulatory

NMPA and Local Governments Streamline Drug Approval Processes in China

Adcendo ApS Secures Oversubscribed USD135 Million Series B Financing to Advance ADC Pipeline
CompanyDeals

Adcendo ApS Secures Oversubscribed USD135 Million Series B Financing to Advance ADC Pipeline

Abbott Laboratories Expands Structural Heart Portfolio with TAVI Balloon-Expandable System
CompanyMedical Device

Abbott Laboratories Expands Structural Heart Portfolio with TAVI Balloon-Expandable System

Merck's Winrevair Shows Positive Results in Phase III ZENITH Study for PAH
CompanyDrug

Merck’s Winrevair Shows Positive Results in Phase III ZENITH Study for PAH

Boston Scientific Corporation to Acquire Intera Oncology Inc., Expanding Cancer Treatment Portfolio
CompanyDeals

Boston Scientific Corporation to Acquire Intera Oncology Inc., Expanding Cancer Treatment Portfolio

Nasal-Phyto Pharmaceutical Receives FDA Clearance for First-Ever Olfactory Drug-Device Combo
CompanyDrug

Nasal-Phyto Pharmaceutical Receives FDA Clearance for First-Ever Olfactory Drug-Device Combo

GSK's Blenrep BLA for Multiple Myeloma Treatments Accepted by FDA for Review
CompanyDrug

GSK’s Blenrep BLA for Multiple Myeloma Treatments Accepted by FDA for Review

Insilico Medicine Gets FDA Approval for Clinical Study of ENPP1 Inhibitor ISM5939
CompanyDrug

Insilico Medicine Gets FDA Approval for Clinical Study of ENPP1 Inhibitor ISM5939

SCG Cell Therapy Presents Phase I Data for HBV-Specific TCR-T Therapy SCG101 at AASLD 2024
CompanyDrug

SCG Cell Therapy Presents Phase I Data for HBV-Specific TCR-T Therapy SCG101 at AASLD 2024

Shenzhen Kangtai Begins Phase I Clinical Trial for 20-Valent Pneumococcal Vaccine
CompanyDrug

Shenzhen Kangtai Begins Phase I Clinical Trial for 20-Valent Pneumococcal Vaccine

Sichuan Kelun-Biotech Receives NMPA Clearance for SKB501 Clinical Trial in Solid Tumors
CompanyDrug

Sichuan Kelun-Biotech Receives NMPA Clearance for SKB501 Clinical Trial in Solid Tumors